Xenon Xe-129 Hyperpolarized Patent Expiration
Xenon Xe-129 Hyperpolarized is Used for a variety of conditions such as depression, anxiety, and nerve pain. It was first introduced by Polarean Inc
Xenon Xe-129 Hyperpolarized Patents
Given below is the list of patents protecting Xenon Xe-129 Hyperpolarized, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xenoview | US10583205 | Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices | Feb 20, 2035 | Polarean |
| Xenoview | US11052161 | Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices | Dec 29, 2035 | Polarean |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Xenon Xe-129 Hyperpolarized's patents.
Latest Legal Activities on Xenon Xe-129 Hyperpolarized's Patents
Given below is the list recent legal activities going on the following patents of Xenon Xe-129 Hyperpolarized.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 23 Aug, 2023 | US10583205 |
| Post Issue Communication - Certificate of Correction | 09 Nov, 2021 | US11052161 |
| Email Notification Critical | 04 Nov, 2021 | US11052161 |
| Mail Certificate of Correction Memo | 03 Nov, 2021 | US11052161 |
| Certificate of Correction Memo | 01 Nov, 2021 | US11052161 |
| Patent Issue Date Used in PTA Calculation Critical | 06 Jul, 2021 | US11052161 |
| Recordation of Patent Grant Mailed Critical | 06 Jul, 2021 | US11052161 |
| Email Notification Critical | 17 Jun, 2021 | US11052161 |
| Issue Notification Mailed Critical | 16 Jun, 2021 | US11052161 |
| Dispatch to FDC | 01 Jun, 2021 | US11052161 |